One objective of a mastitis control program is to avoid which type of residue in milk?

In a mastitis control program, one of the primary objectives is to avoid drug residues in milk. Mastitis is often treated with antibiotics, and if cows are treated while they are lactating, it is crucial to ensure that these drugs do not enter the milk supply. Drug residues can pose significant health risks to consumers and could lead to regulatory consequences for producers, including the potential for economic losses and market access issues.

Implementing a mastitis control program involves monitoring antibiotic use and adhering to appropriate withdrawal times after treatment, ensuring that any residual drugs are no longer present in the milk by the time it is processed for human consumption. This focus on preventing drug residues underscores the importance of safe and legal milk production practices, thereby protecting both public health and dairy market integrity.